Skip to content

Effect of low dose alfentanil pretreatment on sufentanil induced cough response during induction of general anesthesia

Effect of low dose alfentanil pretreatment on sufentanil induced cough response during induction of general anesthesia

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069286
Enrollment
Unknown
Registered
2023-03-12
Start date
2023-03-12
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

experimental group:Alfentanil 2ug/kg

Sponsors

Lishui People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients who had selected thyroid surgery; 2. Aged 18-65 years; 3. American Society of Anesthesiologists (ASA) Grade I ~ II; 4. Cardiac function grade I ~ II.

Exclusion criteria

Exclusion criteria: 1. Smoking history; 2. BMI is greater than 28; 3. Preoperative intracranial, intra-abdominal or intraocular pressure increased; 4. Severe respiratory diseases, such as asthma, chronic cough, lung infection; 5. History of serious nervous system and heart, lung, brain and kidney diseases (such as gastroesophageal reflux, uncontrolled hypertension, diabetes, heart disease); 6. Use cough drugs (such as ACE inhibitors) or antitussive drugs before operation; 7. Long-term drug dependence and psychotic patients; 8. Subjects with opioid allergy; 9. Severe liver function abnormality; 10. Subjects who were judged to have difficulty in respiratory tract management were rated as grade IV by modified Markov score; 11. Known or suspected to be allergic or contraindicated to various components of the study drug or other benzodiazepines, opioids, propofol, muscle relaxants, etc; 12. Those who have participated in any clinical trial as subjects within 3 months before enrollment; 13. Other conditions determined by the researcher to be unsuitable for selection.

Design outcomes

Primary

MeasureTime frame
Incidence and severity of cough;

Secondary

MeasureTime frame
Blood pressure;Heart rate;Pulse oxygen saturation;Nausea and vomiting;Bispectral index of EEG;Peak airway pressure;Tidal volume;Call the opening time;Extubation time;Awakening delay;

Countries

China

Contacts

Public ContactXu Qiaomin

Lishui People's Hospital

xuqiaomin810@163.com+86 189 5709 2672

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026